Sign In

Megha Aggarwal

Postdoctoral Research Associate at Georgia State University

Megha Aggarwal was a Postdoctoral Research Associate at Georgia State University from December 2019 to February 2022.2 She worked at the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.1 Aggarwal was part of a research team that studied the developmental potential of 4'-fluorouridine (4'-FlU), a clinical drug candidate for influenza therapy.1 The study, published in PLoS Pathogens, explored the drug's efficacy against seasonal, pandemic, and highly pathogenic avian influenza viruses.1 Aggarwal's work contributed to findings that showed flu virus variants resistant to this new antiviral drug candidate lost pathogenicity.1

Highlights

Feb 6 · news.gsu.edu
Flu Virus Variants Resistant to New Antiviral Drug Candidate Lose ...
Flu Virus Variants Resistant to New Antiviral Drug Candidate Lose ...
Megha Agarwal - Stanford Profiles
4'-Fluorouridine mitigates lethal infection with pandemic human and ...
Aug 12 · med.stanford.edu
Megha Agarwal - Stanford Medicine

Related Questions

What are Megha Aggarwal's main research interests?
How did Megha Aggarwal contribute to the study on 4’-FlU?
What other studies has Megha Aggarwal been involved in?
What is Megha Aggarwal's educational background?
How long has Megha Aggarwal been at Georgia State University?
Megha Aggarwal
Megha Aggarwal, photo 1
Megha Aggarwal, photo 2
Add to my network

Location

Atlanta, Georgia